Oxytocin and Reward Processing in Women

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 16, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Menstrual CycleHormonal Contraception
Interventions
DRUG

Intranasal oxytocin administration

24 international units (IU) of Syntocinon, nasal spray solution; 1 ml nasal spray contains 40 I.U. oxytocin (equivalent to 67 mcg). One spray hub (0.1 ml) contains 4 I.U. oxytocin (equivalent to 6.7 mcg).

DRUG

Intranasal placebo administration

Nasal spray solution; Placebo will be administered as the placebo controlled condition.

Trial Locations (1)

72076

RECRUITING

University of Tuebingen; Department of Psychiatry & Psychotherapy; Institute of Medical Psychology and Behavioural Neurobiology, Tübingen

Sponsors
All Listed Sponsors
collaborator

University Hospital Tuebingen

OTHER

collaborator

German Research Foundation

OTHER

collaborator

Uppsala University

OTHER

lead

International Research Training Group 2804

OTHER